Resources

A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.

A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.

Resources Index

Blog

Are psychedelics next to treat depression and PTSD?

Recent clinical trials show that psychedelics like LSD, MDMA, and Psilocybin - when properly controlled for dosing and administration - are having positive outcomes in treating mental health disorders. Read about the latest research.

Blog

Find the competitive edge in research and development with IP insights

Learn how incorporating an intellectual property (IP) strategy in research and development plans can give your business a competitive edge.

Press Releases

April19 and CAS collaborate to accelerate real-world application of AI to discovery of novel mental health therapeutics

April19 and CAS collaborate to accelerate real-world application of AI to discovery of novel mental health therapeutics. Pairing curated data and advanced analytics with deep learning approach to drug discovery shortens pipeline and reduces cost.

Blog

Assessing structural novelty of the first AI-designed drug candidates to go into human clinical trials

This blog details the recently published CAS indicator of drug innovation based on the structural novelty of new molecular entities (NMEs) which may better assess innovativeness of new drugs.

Whitepapers

Chemical Inhibitors to RAS Oncoproteins

This whitepaper presents an analysis of the RAS inhibitor landscape, with views based on structural similarity, chemical properties, and patent assignees. See what the insights reveal.

Blog

Emerging trends in targeting "undruggable" RAS proteins for cancer treatment

It is estimated that one in five human cancers involve RAS mutations. Although once considered undruggable, this blog looks at recent advances in RAS inhibitors and emerging therapies.

Blog

Go beyond the label: chemical inventory systems that enable R&D innovation

CAS helps organizations worldwide better utilize scientific information to aid innovation. Here are some tips to ensure you are providing an inventory system that supports research and development.

Blog

Asymmetric Organocatalysis: Selective and Sustainable Synthetic Chemistry Solution Wins 2021 Chemistry Nobel

Benjamin List and David W.C. MacMillan were awarded the 2021 Nobel Prize in Chemistry for their development of a precise new tool for molecular construction: organocatalysis. This has had a great impact on pharmaceutical research, and has made chemistry greener.

Case Studies

iuvo BioScience Uses Improved Data to Accelerate Product Development for Clients

Read how iuvo BioScience teamed with CAS IP Services to help clients move new products from research to release faster, and at a lower cost.